100% found this document useful (2 votes)
762 views4 pages

SWOT Analysis of Beximco Pharmaceuticals

This SWOT analysis examines the strengths, weaknesses, opportunities, and threats for Beximco Pharmaceuticals. Some of Beximco's key strengths include being Bangladesh's largest exporter and possessing a strong brand image and market share. Weaknesses include an inconsistent supply and dependency on foreign products. Opportunities for growth include their global certification and potential to build a stronger brand. Threats include heavy competition, new market entrants, and potential environmental issues. Overall, the analysis finds that Beximco has more advantages than disadvantages if they address weaknesses and leverage strengths.

Uploaded by

Shadman Shahad
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
100% found this document useful (2 votes)
762 views4 pages

SWOT Analysis of Beximco Pharmaceuticals

This SWOT analysis examines the strengths, weaknesses, opportunities, and threats for Beximco Pharmaceuticals. Some of Beximco's key strengths include being Bangladesh's largest exporter and possessing a strong brand image and market share. Weaknesses include an inconsistent supply and dependency on foreign products. Opportunities for growth include their global certification and potential to build a stronger brand. Threats include heavy competition, new market entrants, and potential environmental issues. Overall, the analysis finds that Beximco has more advantages than disadvantages if they address weaknesses and leverage strengths.

Uploaded by

Shadman Shahad
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 4

SWOT analysis of Beximco

Pharmaceuticals
This SWOT analysis of Beximco pharmaceuticals elaborates the strength &
weakness of, opportunities & threats for Beximco pharmaceuticals
Company. It will provide a visual overview that will prompt discussion
around the company’s strategy and situation. This SWOT analysis of
Beximco pharmaceuticals can be used to evaluate the position of their
business. This can be utilized to guide business strategy session of Beximco
pharmaceuticals.

Strengths of Beximco (Internal Strategic Analysis)


Largest exporter in the country: – in the pharmaceuticals sector Beximco is
the largest exporter in Bangladesh. It earns 55% of its revenue from
exports.

Strong brand image: – it has consistently been improving its products and
so the brand image.

Bigger market share: – In Bangladesh, it possesses a bigger market share


than many other giant medication providers. It offers more than 400
products.

Product diversity: – it produces more than 200 generic which are available
in more than 400 different forms, and many of them are leaders among
others.

Foreign market share: – As most of the revenue comes from exporting, it


possesses a large market share in the foreign markets.

Unique product: – it is the first company in Bangladesh to produce ARV


drugs for AIDS/HIV cases.
Corporate social responsibility: – it always has been working for social
improvements. It is connected with much social welfare organization.

Public health checking point: – it has its health checking point where they
can directly communicate with people and gather information. They have
pharmacies almost every division in Bangladesh.

Expert employees: – Beximco Pharma has many experts like chemists,


pharmacists, doctors, MBAs, microbiologists, and engineers who are highly
educated. It makes the company gather more strength in a similar industrial
sector.

Certified by Global regulatory bodies – The global regulatory bodies of the


European Union, Brazil, Australia, Gulf nations, among others certified
Beximco Pharma’s state-of-the-art manufacturing facilities.

Strong R&D: – Beximco Pharmacy is continuously searching for the next


treatment advancements. The portfolio of Beximco features a list of high-
quality, effective products which gave it the advantage to be staying in the
top leading company list in a similar sector.

Weaknesses of Beximco (Internal Strategic


Analysis)
Inconsistent in supplying product: Sometimes they are not able to produce
specific products efficiently; as a result, they cannot supply those products
to retailers timely.

Dependency on foreign products: – Beximco has to import Capsule Cap


from other countries. It’s a big advantage for them to acquire a larger
market. It also imports dry-aluminum hydro-oxide, Dry magnesium hydro-
oxide, and Lutin from abroad.

Strong competitor: – Square pharma has larger market share than Beximco
in Bangladesh, and the difference is stable.
Use of cash for promotional purposes: – they donate money for promoting
their products to the doctors and distributors. Beximco already has a large
market share. If they do not stop this behaviour right now, they may lose
market share in future.

Loan defaulter: – one of the owners of Beximco Pharma did take a loan
from Sonali Bank, and did not pay it back yet. It may harm the company
image in the long term.

Environmental pollution: – for producing purpose, they are polluting water,


and soil in the area where they set up their factories.

Opportunities for Beximco (External Strategic


Analysis)
Enormous Growth – with an employee’s range of more than 2700, the
company is growing day by day which is capable for growing market as well.

Advantage as a globally certified company – it has been certified by


different countries as a reputed medicine manufacturer. It can use this
opportunity to enter other countries.

Building Stronger Brand – as it fulfils social responsibilities, there is a huge


possibility of getting more market share in future.

Threats for Beximco (External Strategic Analysis)


The threat to the environment – as it pollutes environmental elements, if
the Bangladeshi regulatory body takes any steps against it, that may create
a problem for its growing.

Huge competition – first level companies like Square Pharmaceuticals and


Incepta Pharmaceuticals are doing well, and gradually they are gaining more
market shares which are another barrier for Beximco pharmaceuticals.
New Entrants in the market – as the whole country is doing well in the
pharmaceutical sector, the number of newcomers are increasing more than
ever. This may result in declining market shares.

If we closely look at the SWOT Analysis of Beximco pharmaceuticals, we


can see that there are more competitive advantages than the disadvantages.
The strategic operations are highly functional. If weak points are not
overlooked, and proper steps are taken, this company will be able to be
staying in leading position consistently.

You might also like